Key result
NPFF and AR234958 reveal a non-canonical Mas1 receptor activation mechanism driven by hydrophobic compression.
Why the study?
Despite the therapeutic relevance of the Mas1 receptor in cardiovascular and anti-inflammatory regulation, the structural mechanisms underlying its ligand binding and activation remained poorly understood.
Elucidating the cryo-EM structures of the Mas1 receptor provides a structural framework for understanding its non-canonical activation and enables rational design of selective cardiovascular therapeutics.
Opens pathway for selective Mas1 cardiovascular therapeutics; extends understanding of non-canonical GPCR activation.
The Mas1 receptor, an orphan class A G-protein-coupled receptor (GPCR), plays pivotal roles in cardiovascular and anti-inflammatory regulation. Despite its therapeutic relevance, the structural mechanisms underlying Mas1 ligand binding and activation remain poorly understood. Here, we report cryo-EM structures of Mas1 bound to two chemically distinct agonists—neuropeptide FF (NPFF) and synthetic small-molecule AR234958—captured in complex with inhibitory G proteins. These structures reveal a conserved orthosteric binding pocket accommodating both ligands through shared hydrophobic interactions. Unlike many other class A GPCRs that rely on direct W 6.48 toggle switch engagement, Mas1 adopts a non-canonical activation strategy driven by a ligand-induced hydrophobic compression plane involving residues Y248 6.55 , L87 2.60 , I84 2.57 , and L266 7.39 at the bottom of the ligand binding pocket. This mechanism transmits mechanical tension to promote TM6 displacement and G protein coupling. Functional mutagenesis validates this model, identifying two transmembrane helix 6 (TM6) residues, M244 6.51 and F237 6.44 , as critical molecular switches. Comparative analyses of Mas1-related receptors, MRGPRX1–X4, reveal conserved features and mechanistic divergence within this subfamily. These findings provide a structural framework for understanding Mas1 pharmacology and rational design of selective therapeutics.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question. NPFF and AR234958 was evaluated. Cryo-EM structures of the Mas1 receptor bound to NPFF and AR234958 revealed a conserved hydrophobic binding pocket and a non-canonical activation mechanism driven by a hydrophobic compression plane.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: